Company Profile
Company Profile
Greetings
Company Mission / Corporate Credo
Overview / Management Line-up
History
History

Members of Sumitomo Chemical who visited MPI for the negotiations of establishing a joint-venture company(1972)
Members of Sumitomo Chemical who visited MPI for the negotiations of establishing a joint-venture company(1972)

Cyclotron No.1 in operation
Cyclotron No.1 in operation

Ceremony to celebrate the completion of the first phase of construction of the Hyogo Facility
Ceremony to celebrate the completion of the first phase of construction of the Hyogo Facility

ISO14001
JQA-EM1635
Hyogo Facility

ISO14001
JQA-EM1767
Chiba Facility

ISO9001
01808-2007-AQ-KOB-UKAS/JAB
Customer Service Group
Sales Promotion Dept.
1973 Mar. Incorporated as a joint venture of Medi-Physics, Inc.,USA., Sumitomo Chemical Co.,Ltd. and Sumitomo Corporation.
1974 May Construction of Takarazuka Facility completed.
Dec. The first cyclotron installed.
1975 Mar. Nippon Roche K.K. took over the shares formerly owned by Medi-Physics, Inc.
1980 Apr. The first New Town Conference (symposium on cardiovascular nuclear medicine) held.
1981 Dec. The second cyclotron installed.
1983 Oct. Construction of Chiba Facility completed.
1985 Mar. Expansion of Chiba Facility completed.
Jun. The third cyclotron installed.
1986 Jul. The fourth cyclotron installed.
1987 Jul. Business diversified into in vitro diagnostics field.
1990 Jul. Construction of Hyogo Facility completed.
  Dec. The fifth cyclotron, negative ion (H-) type, installed.
1991 Oct. Construction of Central Research Laboratory (currently Research Centre) completed.
1992 May Expansion of Hyogo Facility completed.
Aug. The sixth cyclotron, negative ion (H-) type, installed.
1994 Mar. Nippon Roche K.K. ceased to be a shareholder.
Dec. Amersham International plc, U.K., participated in capital.
1996 Sep. Healthcare businesses of Amersham K.K. integrated into Nihon Medi-Physics.
Oct. Sumitomo Corporation ceased to be a shareholder, and fifty-fifty shareholding between Sumitomo Chemical and Amersham International established.
1997 Oct. As a result of the merger of Amersham International Healthcare and Nycomed (Norway), new company Nycomed Amersham became a shareholder.
2000 Mar. NMP Business Support Co., Ltd., a wholly owned subsidiary established.
2001 Apr. Sumitomo Seiyaku Biochemical Co., Ltd.,
a new company established jointly with Sumitomo Pharmaceuticals for inheriting in vitro diagnostics business separated by both parent companies, started operation.
Jun. Hyogo Facility qualified for "ISO14001".
Sep. Chiba Facility qualified for "ISO14001".
2004 Apr. As a result of take-over of Amersham by General Electric Company(GE), GE Healthcare became a shareholder of Nihon Medi-Physics.
2005 Aug. Enter into the PET diagnostics business.
2007 Feb. Customer Service Group of Sales Promotion Dept. qualified for "ISO9001".